Cymbalta Plaintiffs Working Together to Hold Eli Lilly Responsible

In a recent and ongoing class action against drug maker Eli Lilly, Cymbalta plaintiffs are raising startling and surprisingly common allegations involving the side effects associated with the discontinuation of the drug. Plaintiffs are raising claims of negligence, breach of implied warranties, strict products liability, unjust enrichment and breach of express warranties. The lawsuit involves Cymbalta plaintiffs from across the United States. These plaintiffs have all endured similar experiences after taking Cymbalta and have come forward to seek retribution from careless and predatory drug maker Eli Lilly.

Nature of Cymbalta Plaintiffs’ Claims
The claims made by Cymbalta plaintiffs in the case of Saavedra, et al. v. Eli Lilly and Co. may include symptoms to which you can relate. Specifically, these individuals contend that they endured severe physiological and psychological symptoms when trying to discontinue the use of Cymbalta, including “dizziness, nausea, headaches, fatigue, tingling sensations, vomiting, irritability, nightmares, insomnia, diarrhea, anxiety, excessive sweating and vertigo.”

At the crux of plaintiffs’ claims is the contention that had they known about the likelihood of the onset of any of these side effects, they would have opted not to take the drug all together. In addition, plaintiffs believe that Eli Lilly failed to adequately warn consumers as to the dangers of this drug and should be held liable to any plaintiff who was injured as a result of this failure to warn.

Potential Recovery for Cymbalta Plaintiffs
Cymbalta plaintiffs, as with plaintiffs in any case involving dangerous drugs, could stand to receive compensation for medical expenses, lost wages, pain and suffering, mental anguish or loss of consortium. Plaintiffs are also seeking a declaration that the label affixed to Cymbalta is deceitful and misleading as well as a refund of any money Eli Lilly has acquired as a result of its unfair marketing of Cymbalta. Plaintiffs are seeking compensation for the costs incurred by each to properly withdraw from the dangerous drug as well as court costs, interests and reasonably attorneys’ fees.